CLINICAL RESEARCH
C-Reactive Protein Induces Matrix Metalloproteinase-1 and -10 in Human Endothelial Cells
Implications for Clinical and Subclinical Atherosclerosis
Ines Montero, BS*, ,
Josune Orbe, PhD*, ,
Nerea Varo, PhD,,
Oscar Beloqui, MD, PhD ,
José I. Monreal, MD, PhD,
José A. Rodríguez, PhD*,,
Javier Díez, MD, PhD,
Peter Libby, MD|| and
José A. Páramo, MD, PhD*,,*
* Laboratory of Atherosclerosis
Division of Cardiovascular Sciences
Internal Medicine
Biochemistry Laboratory, School of Medicine/University Clinic, Center for Applied Medical Research, University of Navarra, Pamplona, Spain
|| D.W. Reynolds Foundation Cardiovascular Research Center of Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
Manuscript received August 4, 2005;
revised manuscript received October 4, 2005,
accepted October 10, 2005.
* Reprint requests and correspondence: Dr. José Antonio Páramo, Laboratory of Atherosclerosis, Center for Applied Medical Research (CIMA), Avda Pio XII 55, 31008 Pamplona, Spain (Email: japaramo{at}unav.es).
OBJECTIVES: We examined the effect of C-reactive protein (CRP) on matrix metalloproteinase (MMP) and inhibitor expression in endothelial cells and in patients with clinical and subclinical atherosclerosis.
BACKGROUND: In addition to predicting atherosclerotic vascular disease, CRP may directly promote a proinflammatory/proatherosclerotic phenotype.
METHODS: Human umbilical vein endothelial cells (HUVECs) and aortic endothelial cells (HAECs) were incubated in the presence or absence of CRP (50 µg/ml). Microarray analysis, real-time polymerase chain reaction, immunological and activity assays for MMPs were performed. Specific inhibitors of mitogen-activated protein kinase pathway were used. The MMP-1 and -10 plasma levels were measured in apparently healthy subjects (n = 70). Immunolocalization of CRP, MMP-1, and MMP-10 was performed in human mammary arteries and carotid endarterectomy specimens.
RESULTS: C-reactive protein augmented MMP-1 and -10 messenger ribonucleic acid expression in HUVEC (p < 0.05) and HAEC (p < 0.01). C-reactive protein stimulation also increased MMP-1 and -10 protein in conditioned culture medium (p < 0.001), as well as MMP activity (p = 0.001). Specific inhibition of p38 or MEK abolished the CRP induction of the MMP-1, whereas MMP-10 induction blockade required the simultaneous inhibition of p38 and Jun N-terminal kinase pathways. Subjects with CRP values >3 mg/l (n = 37) had increased plasma MMP-1 and -10 (p < 0.05), the association being significant after adjustment for confounding variables (p = 0.04 and p = 0.008, respectively). The MMP-10 levels were elevated in subjects with higher carotid intima-media thickness (p = 0.009). Increased CRP and MMP-10 colocalized in endothelial layer and macrophage-rich areas in advanced atherosclerotic plaques.
CONCLUSIONS: Increased local and systemic CRP-related MMP activation might provide a link between inflammation and plaque vulnerability.
|
Abbreviations and Acronyms
| | BMI = body mass index | | CCA = common carotid arteries | | CRP = C-reactive protein | | EC = endothelial cell | | ERK = extracellular signal-regulated kinase | | HAEC = human aortic endothelial cell | | HUVEC = human umbilical vein endothelial cell | | IMT = intima-media thickness | | JNK = Jun N-terminal kinase | | MAPK = mitogen-activated protein kinases | | MMP = matrix metalloproteinase | | RT-PCR = reverse transcription-polymerase chain reaction | | TIMP = tissue inhibitor of metalloproteinase | | vWf = von Willebrand factor |
|
This article has been cited by other articles:
|
|
|
|
 
B. D. Lamon and D. P. Hajjar
Inflammation at the Molecular Interface of Atherogenesis: An Anthropological Journey
Am. J. Pathol.,
November 1, 2008;
173(5):
1253 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Maingrette, L. Li, and G. Renier
C-reactive protein enhances macrophage lipoprotein lipase expression
J. Lipid Res.,
September 1, 2008;
49(9):
1926 - 1935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Paramo
A new favourable effect of cocoa on atherosclerosis?
Cardiovasc Res,
July 1, 2008;
79(1):
3 - 4.
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Singh, M. R. Dasu, P. G. Yancey, A. Afify, S. Devaraj, and I. Jialal
Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats
J. Lipid Res.,
May 1, 2008;
49(5):
1015 - 1023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Y. Kassim, S. A. Gharib, B. H. Mecham, T. P. Birkland, W. C. Parks, and J. K. McGuire
Individual Matrix Metalloproteinases Control Distinct Transcriptional Responses in Airway Epithelial Cells Infected with Pseudomonas aeruginosa
Infect. Immun.,
December 1, 2007;
75(12):
5640 - 5650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol.,
April 24, 2007;
49(16):
1740 - 1749.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. T. Miller, P. M. Ridker, P. Libby, and D. J. Kwiatkowski
Atherosclerosis: The Path From Genomics to Therapeutics
J. Am. Coll. Cardiol.,
April 17, 2007;
49(15):
1589 - 1599.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-W. Wu, H.-L. Kao, M.-F. Chen, B.-C. Lee, W.-Y. I. Tseng, J.-S. Jeng, K.-Y. Tzen, R.-F. Yen, P.-J. Huang, and W.-S. Yang
Characterization of Plaques Using 18F-FDG PET/CT in Patients with Carotid Atherosclerosis and Correlation with Matrix Metalloproteinase-1
J. Nucl. Med.,
February 1, 2007;
48(2):
227 - 233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Howard-Alpe, J. W. Sear, and P. Foex
Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers
Br. J. Anaesth.,
December 1, 2006;
97(6):
758 - 769.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Fujii, S.-H. Li, P. E. Szmitko, P. W.M. Fedak, and S. Verma
C-Reactive Protein Alters Antioxidant Defenses and Promotes Apoptosis in Endothelial Progenitor Cells
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2006;
26(11):
2476 - 2482.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, I. Jialal, B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, and I. Jialal
The Verdict Is Still Out
Circulation,
May 2, 2006;
113(17):
2128 - 2151.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Jialal, S. Devaraj, and U. Singh
C-Reactive Protein and the Vascular Endothelium: Implications for Plaque Instability
J. Am. Coll. Cardiol.,
April 4, 2006;
47(7):
1379 - 1381.
[Full Text]
[PDF]
|
|
|
|
